RetinalGenix Technologies Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

RetinalGenix Technologies Inc. reported Cash And Cash Equivalents At Carrying Value of $38.00 for the year ending 2022.

  • RetinalGenix Technologies Inc. showed a decrease of -99.2% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from RetinalGenix Technologies Inc.'s annual report (Form 10-K), filed with the SEC on April 1, 2024.
  • XBRL data for this metric is available from 2020 to 2022 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2020 to 2022), RetinalGenix Technologies Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 98.3%.
  • Historical annual values: Fiscal year 2022: $38.00 | Fiscal year 2021: $4.9 thousand | Fiscal year 2020: $2.2 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: